Development of monoclonal antibody-based immunoassays for detection of Helicobacter pylori neutrophil-activating protein

Ianko D. Iankov, Alan R. Penheiter, Stephanie K Carlson, Evanthia Galanis

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Neutrophil-activating protein (NAP) is a major virulence factor expressed by Helicobacter pylori isolates associated with severe chronic gastroduodenal inflammation and peptic ulcers. NAP is one of the main protective antigens and a target for vaccine development against Helicobacter infection. In addition, NAP is a potent immune stimulator with potential application as a general vaccine adjuvant and in treatment of allergic diseases and cancer immunotherapy. NAP-specific immunoassays are needed for both H. pylori diagnostics and characterization of NAP-based vaccines and immunomodulatory preparations. We generated a panel of NAP-specific monoclonal antibodies (MAbs) by immunization of BALB/c mice with synthetic NAP peptides. The antibody reactivity against recombinant or native NAP antigen was characterized by enzyme-linked immunosorbent assay (ELISA), immunoblotting and immunofluorescence. A sensitive capture ELISA was developed using MAbs 23C8 and 16F4 (directed against different NAP epitopes) for detection of native or measles virus (MV) vector-expressed recombinant NAP in a concentration range of 4. ng/ml to 2000. ng/ml. MAb 23C8 antigen-binding depends on Tyr101 in a variable amino acid sequence of the NAP molecule, indicating the existence of antigenic variants among H. pylori strains. MAb 16F4 reacted with NAP from different H. pylori strains and was a sensitive tool for detection of small amounts of isolated NAP antigen or whole bacteria by immunoblotting or immunofluorescence. In conclusion, MAb-based immunoassays are highly specific and sensitive for detection of native NAP antigen and recombinant NAP immunostimulatory transgenes expressed by replication competent virus vectors.

Original languageEnglish (US)
Pages (from-to)1-9
Number of pages9
JournalJournal of Immunological Methods
Volume384
Issue number1-2
DOIs
StatePublished - Oct 31 2012

Fingerprint

Immunoassay
Neutrophils
Monoclonal Antibodies
Proteins
Antigens
Helicobacter pylori
Vaccines
Helicobacter pylori neutrophil-activating protein A
Peptic Ulcer
Immunoblotting
Fluorescent Antibody Technique
Enzyme-Linked Immunosorbent Assay
Measles virus
Helicobacter Infections
Virulence Factors
Virus Replication
Transgenes
Recombinant Proteins
Immunotherapy
Epitopes

Keywords

  • Helicobacter pylori
  • Immunoassays
  • Monoclonal antibody
  • NAP

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Development of monoclonal antibody-based immunoassays for detection of Helicobacter pylori neutrophil-activating protein. / Iankov, Ianko D.; Penheiter, Alan R.; Carlson, Stephanie K; Galanis, Evanthia.

In: Journal of Immunological Methods, Vol. 384, No. 1-2, 31.10.2012, p. 1-9.

Research output: Contribution to journalArticle

@article{f8179f394cd146db826ceec849c1da20,
title = "Development of monoclonal antibody-based immunoassays for detection of Helicobacter pylori neutrophil-activating protein",
abstract = "Neutrophil-activating protein (NAP) is a major virulence factor expressed by Helicobacter pylori isolates associated with severe chronic gastroduodenal inflammation and peptic ulcers. NAP is one of the main protective antigens and a target for vaccine development against Helicobacter infection. In addition, NAP is a potent immune stimulator with potential application as a general vaccine adjuvant and in treatment of allergic diseases and cancer immunotherapy. NAP-specific immunoassays are needed for both H. pylori diagnostics and characterization of NAP-based vaccines and immunomodulatory preparations. We generated a panel of NAP-specific monoclonal antibodies (MAbs) by immunization of BALB/c mice with synthetic NAP peptides. The antibody reactivity against recombinant or native NAP antigen was characterized by enzyme-linked immunosorbent assay (ELISA), immunoblotting and immunofluorescence. A sensitive capture ELISA was developed using MAbs 23C8 and 16F4 (directed against different NAP epitopes) for detection of native or measles virus (MV) vector-expressed recombinant NAP in a concentration range of 4. ng/ml to 2000. ng/ml. MAb 23C8 antigen-binding depends on Tyr101 in a variable amino acid sequence of the NAP molecule, indicating the existence of antigenic variants among H. pylori strains. MAb 16F4 reacted with NAP from different H. pylori strains and was a sensitive tool for detection of small amounts of isolated NAP antigen or whole bacteria by immunoblotting or immunofluorescence. In conclusion, MAb-based immunoassays are highly specific and sensitive for detection of native NAP antigen and recombinant NAP immunostimulatory transgenes expressed by replication competent virus vectors.",
keywords = "Helicobacter pylori, Immunoassays, Monoclonal antibody, NAP",
author = "Iankov, {Ianko D.} and Penheiter, {Alan R.} and Carlson, {Stephanie K} and Evanthia Galanis",
year = "2012",
month = "10",
day = "31",
doi = "10.1016/j.jim.2012.06.010",
language = "English (US)",
volume = "384",
pages = "1--9",
journal = "Journal of Immunological Methods",
issn = "0022-1759",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Development of monoclonal antibody-based immunoassays for detection of Helicobacter pylori neutrophil-activating protein

AU - Iankov, Ianko D.

AU - Penheiter, Alan R.

AU - Carlson, Stephanie K

AU - Galanis, Evanthia

PY - 2012/10/31

Y1 - 2012/10/31

N2 - Neutrophil-activating protein (NAP) is a major virulence factor expressed by Helicobacter pylori isolates associated with severe chronic gastroduodenal inflammation and peptic ulcers. NAP is one of the main protective antigens and a target for vaccine development against Helicobacter infection. In addition, NAP is a potent immune stimulator with potential application as a general vaccine adjuvant and in treatment of allergic diseases and cancer immunotherapy. NAP-specific immunoassays are needed for both H. pylori diagnostics and characterization of NAP-based vaccines and immunomodulatory preparations. We generated a panel of NAP-specific monoclonal antibodies (MAbs) by immunization of BALB/c mice with synthetic NAP peptides. The antibody reactivity against recombinant or native NAP antigen was characterized by enzyme-linked immunosorbent assay (ELISA), immunoblotting and immunofluorescence. A sensitive capture ELISA was developed using MAbs 23C8 and 16F4 (directed against different NAP epitopes) for detection of native or measles virus (MV) vector-expressed recombinant NAP in a concentration range of 4. ng/ml to 2000. ng/ml. MAb 23C8 antigen-binding depends on Tyr101 in a variable amino acid sequence of the NAP molecule, indicating the existence of antigenic variants among H. pylori strains. MAb 16F4 reacted with NAP from different H. pylori strains and was a sensitive tool for detection of small amounts of isolated NAP antigen or whole bacteria by immunoblotting or immunofluorescence. In conclusion, MAb-based immunoassays are highly specific and sensitive for detection of native NAP antigen and recombinant NAP immunostimulatory transgenes expressed by replication competent virus vectors.

AB - Neutrophil-activating protein (NAP) is a major virulence factor expressed by Helicobacter pylori isolates associated with severe chronic gastroduodenal inflammation and peptic ulcers. NAP is one of the main protective antigens and a target for vaccine development against Helicobacter infection. In addition, NAP is a potent immune stimulator with potential application as a general vaccine adjuvant and in treatment of allergic diseases and cancer immunotherapy. NAP-specific immunoassays are needed for both H. pylori diagnostics and characterization of NAP-based vaccines and immunomodulatory preparations. We generated a panel of NAP-specific monoclonal antibodies (MAbs) by immunization of BALB/c mice with synthetic NAP peptides. The antibody reactivity against recombinant or native NAP antigen was characterized by enzyme-linked immunosorbent assay (ELISA), immunoblotting and immunofluorescence. A sensitive capture ELISA was developed using MAbs 23C8 and 16F4 (directed against different NAP epitopes) for detection of native or measles virus (MV) vector-expressed recombinant NAP in a concentration range of 4. ng/ml to 2000. ng/ml. MAb 23C8 antigen-binding depends on Tyr101 in a variable amino acid sequence of the NAP molecule, indicating the existence of antigenic variants among H. pylori strains. MAb 16F4 reacted with NAP from different H. pylori strains and was a sensitive tool for detection of small amounts of isolated NAP antigen or whole bacteria by immunoblotting or immunofluorescence. In conclusion, MAb-based immunoassays are highly specific and sensitive for detection of native NAP antigen and recombinant NAP immunostimulatory transgenes expressed by replication competent virus vectors.

KW - Helicobacter pylori

KW - Immunoassays

KW - Monoclonal antibody

KW - NAP

UR - http://www.scopus.com/inward/record.url?scp=84865592602&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865592602&partnerID=8YFLogxK

U2 - 10.1016/j.jim.2012.06.010

DO - 10.1016/j.jim.2012.06.010

M3 - Article

C2 - 22750540

AN - SCOPUS:84865592602

VL - 384

SP - 1

EP - 9

JO - Journal of Immunological Methods

JF - Journal of Immunological Methods

SN - 0022-1759

IS - 1-2

ER -